Kura Oncology, Inc.
DE ˙ DB ˙ US50127T1097
7,56 € ↑0,24 (3,28%)
2026-06-05
CENA AKCJI
SecurityDE:KUR / Kura Oncology, Inc.
InstitutionJanus Henderson Group Plc
Latest Disclosed Ownership24,922 shares
Latest Disclosed Value $ 202,491
Janus Henderson Group Plc ownership in KUR / Kura Oncology, Inc.

On May 18, 2026 - Janus Henderson Group Plc filed a 13F-HR/A form disclosing ownership of 24,922 shares of Kura Oncology, Inc. (DE:KUR) valued at $165,731 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 24,922 shares of Kura Oncology, Inc.. This represents a change in shares of 0.00% during the quarter. The current value of the position is $188,410 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-18 2026-03-31 13F/A-1 KURA ONCOLOGY COM 50127T109 24,922 0 0.00 202 -21.71 0.0000
2026-05-15 2026-03-31 13F KURA ONCOLOGY COM 50127T109 24,922 0 202 0.0000
2026-02-17 2025-12-31 13F KURA ONCOLOGY COM 50127T109 24,922 0 0.00 259 17.27 0.0001
2025-11-14 2025-09-30 13F KURA ONCOLOGY COM 50127T109 24,922 -561,909 -95.75 221 -93.50 0.0001
2025-08-14 2025-06-30 13F KURA ONCOLOGY COM 50127T109 586,831 561,909 2,254.67 3,386 1,834.29 0.0017
2025-05-15 2025-03-31 13F KURA ONCOLOGY COM 50127T109 24,922 0 0.00 176 -18.98 0.0001
2025-02-14 2024-12-31 13F KURA ONCOLOGY COM 50127T109 24,922 0 0.00 217 -55.56 0.0001
2024-11-14 2024-09-30 13F KURA ONCOLOGY COM 50127T109 24,922 0 0.00 487 -5.08 0.0002
2024-08-14 2024-06-30 13F KURA ONCOLOGY COM 50127T109 24,922 -341 -1.35 513 -4.83 0.0003
2024-05-15 2024-03-31 13F KURA ONCOLOGY COM 50127T109 25,263 2 0.01 538 48.21 0.0003
2024-02-14 2023-12-31 13F KURA ONCOLOGY COM 50127T109 25,261 -74 -0.29 364 57.14 0.0002
2023-11-14 2023-09-30 13F KURA ONCOLOGY COM 50127T109 25,335 39 0.15 231 -13.48 0.0002
2023-08-14 2023-06-30 13F KURA ONCOLOGY COM 50127T109 25,296 -43 -0.17 267 -13.87 0.0002
2023-05-15 2023-03-31 13F KURA ONCOLOGY COM 50127T109 25,339 13,851 120.57 310 118.31 0.0002
2023-02-14 2022-12-31 13F KURA ONCOLOGY COM 50127T109 11,488 0 0.00 142 -9.55 0.0001
2023-01-13 2022-09-30 13F/A-1 KURA ONCOLOGY COM 50127T109 11,488 19 0.17 157 -25.24 0.0001
2022-11-14 2022-09-30 13F KURA ONCOLOGY COM 50127T109 11,488 19 157 0.0001
2022-08-15 2022-06-30 13F KURA ONCOLOGY COM 50127T109 11,469 -15 -0.13 210 13.51 0.0001
2022-05-16 2022-03-31 13F KURA ONCOLOGY COM 50127T109 11,484 2 0.02 185 14.91 0.0001
2022-02-14 2021-12-31 13F KURA ONCOLOGY COM 50127T109 11,482 11,482 161 0.0001
2021-05-17 2021-03-31 13F KURA ONCOLOGY COM 50127T109 0 -86,038 -100.00 0 -100.00
2021-02-16 2020-12-31 13F KURA ONCOLOGY COM 50127T109 86,038 86,038 2,810 0.0013
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.